VivoSim Labs, Inc. Accounts Payable
VivoSim Labs, Inc. (VIVS) had Accounts Payable of $621.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-12
- 2026-06-30: Accounts Payable, Current $621.00K.
- 2026-03-31: Accounts Payable, Current $1.02M.
- 2025-12-31: Accounts Payable, Current $671.00K.
- 2025-09-30: Accounts Payable, Current $580.00K.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $621.00K 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $1.02M 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $671.00K 10-Q · filed 2026-02-11 | |
| 2025-09-30 | $580.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $673.00K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $1.64M 10-K · filed 2026-07-14 | |
| 2024-12-31 | $930.00K 10-Q · filed 2025-02-19 | |
| 2024-09-30 | $419.00K 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $1.12M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $627.00K 10-K · filed 2025-06-05 | |
| 2023-12-31 | $471.00K 10-Q · filed 2024-02-08 | |
| 2023-09-30 | $435.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $488.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $331.00K 10-K · filed 2024-05-31 | |
| 2022-12-31 | $242.00K 10-Q · filed 2023-02-09 | |
| 2022-09-30 | $441.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $130.00K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $415.00K 10-K · filed 2023-07-14 | |
| 2021-12-31 | $605.00K 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $958.00K 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $577.00K 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $281.00K 10-K · filed 2022-06-10 | |
| 2020-12-31 | $411.00K 10-Q · filed 2021-02-08 | |
| 2020-09-30 | $201.00K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $110.00K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $720.00K 10-K · filed 2021-06-15 | |
| 2019-12-31 | $822.00K 10-Q · filed 2020-02-10 | |
| 2019-09-30 | $152.00K 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $553.00K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $628.00K 10-K · filed 2020-05-28 | |
| 2018-12-31 | $647.00K 10-Q · filed 2019-02-07 | |
| 2018-09-30 | $449.00K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $396.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $464.00K 10-K · filed 2019-06-03 | |
| 2017-12-31 | $452.00K 10-Q · filed 2018-02-08 | |
| 2017-09-30 | $477.00K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $558.00K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $1.17M 10-K · filed 2018-05-31 | |
| 2016-12-31 | $722.00K 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $754.00K 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $481.00K 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $787.00K 10-K · filed 2017-06-07 | |
| 2015-12-31 | $466.00K 10-Q · filed 2016-02-08 | |
| 2015-09-30 | $567.00K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $1.03M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $1.39M 10-K · filed 2016-06-09 | |
| 2014-12-31 | $495.00K 10-Q · filed 2015-02-06 | |
| 2014-09-30 | $530.00K 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $839.00K 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $326.00K 10-K · filed 2015-06-09 | |
| 2013-12-31 | $311.00K 10-Q · filed 2014-02-06 | |
| 2013-09-30 | $477.00K 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $374.00K 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $641.00K 10-K · filed 2014-06-10 | |
| 2012-12-31 | $425.00K 10-K · filed 2014-06-10 | |
| 2012-09-30 | $61.35K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $259.52K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $440.89K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $658.00K 10-KT · filed 2013-05-24 | $61.20K 10-Q · filed 2012-01-17 |
| 2011-09-30 | $28.87K 10-Q · filed 2011-10-31 | |
| 2011-06-30 | $10.69K 10-Q · filed 2012-01-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |